Jim Simons’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History

Jim Simons’s Portfolio TSRX Stock Details TSRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-65,061	Closed	-$527K	–	3112
2013 Q2	$527K	Buy	+65,061	New	+$481K	﹤0.01%	2215

Other funds holding TSRX

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 27.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Jim Simons's TSRX Position: Q3 2013 in Review

Jim Simons sold out of TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) in Q3 2013, closing a stake of 65,061 shares — an estimated $527K sold.

Jim Simons first reported a position in TSRX in Q2 2013 and held it in 1 quarter. The position peaked at $527K in Q2 2013. 7 funds tracked by Wall St. Rank hold TSRX as of Q3 2013.

Jim Simons reported no remaining TRIUS THERAPEUTICS INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
Jim Simons sold 65,061 TRIUS THERAPEUTICS INC COM STK (DE) shares in Q3 2013, an estimated $527K.
Jim Simons first reported a position in TRIUS THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
Jim Simons's TRIUS THERAPEUTICS INC COM STK (DE) position peaked at $527K in Q2 2013.
7 funds tracked by Wall St. Rank held TRIUS THERAPEUTICS INC COM STK (DE) as of Q3 2013.

Based on Renaissance Technologies's 13F filing for Q3 2013, filed 13 Nov 2013.